Highlander Health: Data-Driven Innovation in Medicine
Podcast Episode · Healthcare Unfiltered · 02/10/2025 · 41m
Related Articles
Statin Therapy in Recipients of Kidney Allografts: Review and Meta-Analysis | Docwire News
A study assessed the safety of statin use in kidney allograft recipients and potential effects of statins on the risk of cardiovascular events, mortality, and…
US foreign aid freeze wreaks havoc for HIV treatment in Africa – The World from PRX
With recent cuts to foreign aid, including programs like PEPFAR, thousands of Africans living with HIV face an uncertain future. Although the freeze was followed…
TREATT Trial Evaluates Tranexamic Acid for Bleeding Prevention in Hematologic Malignancies | Blood Cancers Today
Compared with placebo, tranexamic acid did not reduce bleeding in patients with hematologic malignancies and severe thrombocytopenia undergoing intensive chemotherapy.
Program Guide – ASCO Meeting Program Guide
William Aronson , Tristan Grogan , Pei Liang , Patricia Jardack , Amana Liddell , Claudia Perez , Mikayla Lerman , David Elashoff , Jonathan…
Left atrial-to-coronary sinus shunting in HFmrEF/HFpEF The ALT-FLOW Trial (Early Feasibility Study) 2-year results:
ABSTRACTBackgroundThe ALT-FLOW Early Feasibility Study (EFS) evaluated safety, hemodynamics and outcomes for the APTURE system in patients with HF and mildly reduced or preserved ejection…
Reprieve System for the Treatment of Patients with Acute Decompensated Heart Failure
Congestive symptoms are the predominant reason for acute decompensated heart failure (ADHF) hospitalization.1,2 Despite the goal of alleviating congestion, approximately 25-30% of patients have residual…
JACC Journals at THT 2025 | Journal of the American College of Cardiology
Join JACC: Basic to Translational Science and JACC: Heart Failure at THT as we showcase groundbreaking advancements in heart failure research and technology. From AI-enabled…
Drugs.com – Prescription Drug Information
Providing accurate, impartial information on more than 24,000 prescription drugs and OTC medications.
Botensilimab and Balstilimab for Refractory MSS mCRC | Docwire News
Dr. Marwan Fakih of City of Hope discusses the phase 2 study of botensilimab and balstilimab for the treatment of refractory microsatellite stable metastatic colorectal…
Optimizing MDS Management: Key Takeaways from the COMMANDS Trial | Blood Cancers Today
Thomas LeBlanc, MD, MA; Andrew Brunner, MD; and Jamie Koprivnikar, MD, discuss the COMMANDS trial and sequencing luspatercept in patients with myelodysplastic syndromes.